MAPS) has been awarded a $12,979,050 grant from Michigan’s $20 million competitive 2021 Veteran Marijuana Research Grant Program. The program, which is funded by adult-use marijuana retail taxes, is …
We’ve finally reached the point where we can shout our good news from the roof tops and publicly celebrate the work of this amazing team! The publication of our MAPP1 findings is official as of this …
McKenna Haynes and Robert Hallock, Ph.D Department of Psychology Purdue University This is roughly a 20 minute, completely anonymous survey that considers what the public has used psilocybin for during …
On May 12, 2020, a new protocol amendment which increases the number of study participants to a total of 120 was accepted by the U.S. Food and Drug Administration (FDA). This protocol amendment was submitted …
As of January 17, 2020, 89 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
As of December 18, 2019, 87 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
As of November 15, 2019, 83 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
On Tuesday, October 15, researchers from MAPS Public Benefit Corporation (MAPS PBC) conducted the official site initiation visit for our new study site location in Santa Fe, New Mexico, for our ongoing …
We are launching a third study location in Santa Fe, New Mexico, for our ongoing therapist training study, which also takes place in Boulder, Colorado, and Charleston, South Carolina. The new study site …
As of August 28, 2019, 81 total participants are enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this …
On June 5, 2019, the 79th participant enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this multi-site …
On May 15, 2019, the 76th participant enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this multi-site …
